Download pharmacokinetics-3

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Stimulant wikipedia , lookup

Biosimilar wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Orphan drug wikipedia , lookup

Psychopharmacology wikipedia , lookup

Compounding wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Bad Pharma wikipedia , lookup

Pharmacognosy wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Theralizumab wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Neuropharmacology wikipedia , lookup

Medication wikipedia , lookup

Prescription costs wikipedia , lookup

Plateau principle wikipedia , lookup

Drug design wikipedia , lookup

Drug discovery wikipedia , lookup

Drug interaction wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Transcript
Pharmacokinetics
• Based on the hypothesis that the action of a
drug requires presence of a certain
concentration in the fluid bathing the target
tissue.
• In other words, the magnitude of response
(good or bad) depends on concentration of
the drug at the site of action
Pharmacokinetics
•
•
•
•
Absorption
Distribution
Metabolism
Elimination
Study of [drug] over time
How are [drug] measured?
• Invasive: blood, spinal fluid, biopsy
• Noninvasive: urine, feces, breath, saliva
• Most analytical methods designed for
plasma analysis
• C-14, H-3
Therapeutic Window
• Useful range of concentration over which a drug is
therapeutically beneficial. Therapeutic window
may vary from patient to patient
• Drugs w/ narrow therapeutic windows require
smaller & more frequent doses or a different
method of administration
• Drugs w/ slow elimination rates may rapidly
accumulate to toxic levels….can choose to give
one large initial dose, following only with small
doses
Shape different for IV injection
Distribution
• Rate & Extent depend upon
–
–
–
–
–
Chemical structure of drug
Rate of blood flow
Ease of transport through membrane
Binding of drug to proteins in blood
Elimination processes
• Partition Coefficients: ratio of solubility of
a drug in water or in an aqueous buffer to its
solubility in a lipophilic, non-polar solvent
• pH and ionization: Ion Trapping
The Compartment Model
• WE can generally think of the body as a
series of interconnected well-stirred
compartments within which the [drug]
remains fairly constant. BUT movement
BETWEEN compartments important in
determining when and for how long a drug
will be present in body.
Partitioning into body fat and
other tissues

A large, nonpolar compartment. Fat has
low blood supply—less than 2% of cardiac output,
so drugs are delivered to fat relatively slowly
•For practical purposes: partition into body fat
important following acute dosing only for a few
highly lipid-soluble drugs and environmental
contaminants which are poorly metabolized and
remain in body for long period of time
IMPORTANT EFFECTS OF PH
PARTITIONING:

urinary acidification will accelerate the
excretion of weak bases and retard that of weak
acids; alkalination has the opposite effects

increasing plasma pH (by addition of
NaHCO3) will cause weakly acidic drugs to be
extracted from the CNS into the plasma; reducing
plasma pH (by administering a carbonic anhydrase
inhibitor) will cause weakly acidic drugs to be
concentrated in the CNS, increasing their toxicity
Renal Elimination
• Glomerular filtration: molecules below 20 kDa
pass into filtrate. Drug must be free, not protein
bound.
• Tubular secretion/reabsorption: Active transport.
Followed by passive & active. DP=D + P. As D
transported, shift in equilibrium to release more
free D. Drugs with high lipid solubility are
reabsorbed passively & therefore slowly excreted.
Idea of ion trapping can be used to increase
excretion rate---traps drug in filtrate.
Plasma Proteins that Bind Drugs
• albumin: binds many acidic drugs and a
few basic drugs
 b-globulin and an a1acid glycoprotein
have also been found to bind certain basic
drugs
A bound drug has no effect!
•
•
•
•
Amount bound depends on:
1) free drug concentration
2) the protein concentration
3) affinity for binding sites
% bound: __[bound drug]__________ x 100
[bound drug] + [free drug]
% Bound
• Renal failure, inflammation, fasting,
malnutrition can have effect on plasma
protein binding.
• Competition from other drugs can also
affect % bound.
An Example
• warfarin (anticoagulant) protein bound ~98%
• Therefore, for a 5 mg dose, only 0.1 mg of drug is
free in the body to work!
• If pt takes normal dose of aspirin at same time
(normally occupies 50% of binding sites), the
aspirin displaces warfarin so that 96% of the
warfarin dose is protein-bound; thus, 0.2 mg
warfarin free; thus, doubles the injested dose
Volume of Distribution
• C = D/Vd
– Vd is the apparent volume of distribution
– C= Conc of drug in plasma at some time
– D= Total conc of drug in system\
Vd gives one as estimate of how well the drug is
distributed. Value < 0.071 L/kg indicate the drug
is mainly in the circulatory system. Values >
0.071 L/kg indicate the drug has gotten into
specific tissues.
Conc. Vs. time plots
C = Co - kt
ln C = ln Co - kt
Types of Kinetics Commonly
Seen
Zero Order Kinetics
First Order Kinetics
• Rate = k
• C = Co - kt
• Rate = k C
• C = Co e-kt
• C vs. t graph is
LINEAR
• C vs. t graph is NOT
linear, decaying
exponential. Log C
vs. t graph is linear.
First-Order Kinetics
Comparison
• First Order Elimination
– [drug] decreases
exponentially w/ time
– Rate of elimination is
proportional to [drug]
– Plot of log [drug] or
ln[drug] vs. time are
linear
– t 1/2 is constant regardless
of [drug]
• Zero Order Elimination
– [drug] decreases linearly
with time
– Rate of elimination is
constant
– Rate of elimination is
independent of [drug]
– No true t 1/2
Half-Life
• C = Co e - kt
• C/Co = 0.50 for half of the original amount
• 0.50 = e – k t
• ln 0.50 = -k t ½
• -0.693 = -k t ½
• t 1/2 = 0.693 / k
Use of t 1/2 & kel data
• If drug has short duration of action, design
drug with larger t 1/2 & smaller kel
• If drug too toxic, design drug with
smaller t 1/2 & larger kel
Clearance
• Volume of blood in a defined region of the
body that is cleared of a drug in a unit time.
• Clearance is a more useful concept in reality
than t 1/2 or kel since it takes into account
blood flow rate
• Clearance varies with body weight
• Also varies with degree of protein binding
Clearance
• Rate of elimination = kel D,
– Remembering that C = D/Vd
– And therefore D= C Vd
– Rate of elimination = kel C Vd
• Rate of elimination for whole body = CLT C
Combining the two,
CLT C = kel C Vd and simplifying gives:
CLT = kel Vd
Problem 5.5
Problem 5.5
7
6
Conc. Drug (ug/cm 3)
5
4
Series1
3
2
1
0
0
1
2
3
4
tim e (hr)
5
6
7
problem 5.5
2
1.8
1.6
y = -0.2249x + 1.9953
R2 = 0.9997
1.4
log C
1.2
Series1
1
Linear (Series1)
0.8
0.6
0.4
0.2
0
0
1
2
3
4
tim e (hr)
5
6
7
Problem 5.5
• Calculate kel
• C = Co e-kt
• ln C – ln Co = - k t
• Calculate Vd
• C = D/Vd
• Calculate CL
• CLT = kel Vd
AUC: IV Administration
AUC
• For IV bolus, the AUC represents the total
amount of drug that reaches the circulatory
system in a given time.
• Dose = CLT AUC
AUC: Oral Administration
Bioavailability
• The fraction of the dose of a drug (F) that
enters the general circulatory system,
F= amt. Of drug that enters systemic circul.
Dose administered
F = AUC/Dose
Bioavailability
• A concept for oral administration
• Useful to compare two different drugs or different
dosage forms of same drug
• Rate of absorption depends, in part, on rate of
dissolution (which in turn is dependent on
chemical structure, pH, partition coefficient,
surface area of absorbing region, etc.) Also firstpass metabolism is a determining factor